diagnosed with autoimmune encephalitis (10) postuve serum and CSF result if Anti-NMDA, Anti MOG, Systemic Lupus, and (5) case has seronegative autoimmune encephalitis with presence of the other feature
right predominant frontal gyrus, second rate parietal lobule (IPL), and center occipital gyrus (MOG) when responding to social commend, and increments in right SFG and IPL and diminishes in cleared
negative. MRI Brain was normal. Anti NMO panel (anti-Aquaporin 4 antibody and anti- MOG antibody) was negative. ANA, anti- Ro/anti- SSA and anti-La/anti-SSB were positive
negative. MRI Brain was normal. Anti NMO panel (anti-Aquaporin 4 antibody and anti- MOG antibody) was negative. ANA, anti- Ro/anti- SSA and anti-La/anti-SSB were positive
with PEG-400 (AMD) or treated by intraperitoneal injection of the Myelin Oligodendrocyte Glycoprotein (MOG) (optic neuritis). We present here data showing that treatment of these animals by oral administration
nervous system of dcf1 knockout mice, in addition to MBP, the expression of MAG, MOG and CNPase were also lower significantly. We observed that the myelin was obvious thinner; uncompact
mice were placed in 8 therapeutic groups. Mice were immunized with myelin oligodendrocyte glycoprotein (MOG) 35–55. When EAE was observed¸ HU-210 was subcutaneously administered in 3 groups with
variant into the mouse CX3CR1 locus. Active EAE was induced in humanized mice via MOG(35-55) peptide immunization. Our results show an exacerbated EAE phenotype in mice expressing
clinically diagnosed with M.S disease revealed ANA reactivity followed by 15 (5.57%) showing anti-MOG (anti-myelin oligodendrocyte glycoprotein) and 1 (0.37%) Aquaporin-4 antibodies (NMO-IgG/neuromyelitis optica
this work to the clinic. Figure 1: IL-4 ameliorated disease progression in Bl6 MOG EAE mice injected intrathecally for two weeks with IL-4 or PBS during the chronic
significant between the two groups. Cytokine measurements in spleen cell soup, stimulated with MOG protein, showed a significant decrease in INF-γ and IL-17 in the treatment group
kgBW Aloe vera extract), group 4 (the rats with myelin oligodendrocyte glycoprotein (MOG) peptide-induced MS), group 5 (the rats with experimental MS, which received 200 mg/kgBW of Aloe
study of MS, including myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-induced EAE) and cuprizone induced demyelination/remyelination. Gas6 is the sole ligand for the Axl…
tuftsin, immunomodulatory tetrapeptide shown to polarize microglia to the M2 phenotype in a MOG-induced acute EAE model. We examined effects on disease course, demyelination and microglial infiltration and polarization
levels and gene expressions (Tbet, RORÃ?³t and FoxP3) of essential cytokines, after induction (MOG) in the C57BL/6 mice using EAE scoring method, splenocyte cell culture, ELISA, flow cytometer
five encephalitogenic T-cell lines, each specific for a different encephalitogenic epitope of MBP, MOG, PLP, MOBP and OSP. Strikingly, Y-MSPc was consistently more effective than treatment with
glucosylated Asn present in the 30-50 fragment of the myelin oligodentrocyte glycoprotein (MOG (30-50)) is an immunogenic epitope responsible for the interaction with MS auto antibodies. Starting from
animal model of MS, experimental autoimmune encephalomyelitis (EAE). EAE induction was done using MOG in C57/Bl6 mice. Therapeutic administration of different doses of highly selective NR2B-containing NMDAR inhibitor
method strips grain rich material with a reduced amount of materials other than grain (MOG). A laboratory stripper rig designed for this studyconsists of three major components; a mounted stripper
myelin basic protein (MBP), 2’,3’-cyclic nucleotide 3’-phosphodiesterase (CNPase), myelin oligodendrocyte glycoprotein (MOG), and proteolipid protein (PLP) in human primary oligodendrocytes. Combination of IFN-γ and…
delivery of GAS6 directly into the CNS of WT mice during myelin oligodendrocyte glycoprotein (MOG)-induced EAE would improve the clinical course of disease relative to artificial cerebrospinal fluid (ACSF
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.